Floatz logo

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter

Estrogen Receptor Negative

Mayo Clinicgene_therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Estrogen Receptor Negative cohort.

Asset / SponsorPhaseRating
Carboplatin
Northwestern University
Phase 3BBB
Pembrolizumab
Massachusetts General Hospital
Phase 2BB
Epirubicin
Massachusetts General Hospital
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
University of Washington
Phase 3BB
Cyclophosphamide
Massachusetts General Hospital
Phase 3BB

View all 50 →

Same molecule, other indications

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter is also rated in:

primary peritoneal carcinomaDormant
B
Indicative ·
63 / 100
View asset →
fallopian tube serous adenocarcinomaDormant
B
Indicative ·
59 / 100
View asset →
fallopian tube mucinous adenocarcinomaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →